FDA Pharamacogenomic Biomarker Database

Posted by cdavenport on Thursday Jul 5, 2012 Under Databases, Drug Safety, FDA, Genetic Toxicology, Regulatory

Pharmacogenomics can play an important role in identifying responders and non-responders to medications, avoiding adverse events, and optimizing drug dose. Drug labels may contain information on genomic biomarkers and can describe:

    • Drug exposure and clinical response variability
    • Risk for adverse events
    • Genotype-specific dosing
    • Mechanisms of drug action
    • Polymorphic drug target and disposition genes

This resource table lists FDA-approved drugs with pharmacogenomic information / biomarkers in their labels.

Source:  FDA

Be Sociable, Share!

2 Responses to “FDA Pharamacogenomic Biomarker Database”

  1. Peter Xu, Ph.D., DABT Says:

    Please share me some information, and I can donate some ideas and expereince as well.

  2. cdavenport Says:


    Thanks for your comment! Other than the information contained in the FDA source article cited above, I do not have further information on this initiative.
    Genomics > Table of Pharmacogenomic Biomarkers in Drug Labels http://bit.ly/FDAgenomicDatabase


Leave a Reply